AbbVie shares hit record high as

AbbVie股价创历史新高,关键免疫学药物专利保护期延至2037年

By Christy Santhosh

作者:Christy Santhosh

September 12, 2025

2025年9月12日

AbbVie shares rose 4% to a record high on Thursday after the U.S. drugmaker said it expected no generic competition for its blockbuster immunology drug Rinvoq until 2037, a four-year extension, according to some analysts.

⋯ 继续阅读请登录会员 ⋯